|
Natural
Products for Dyslipidemias
Please
read through the following information and click continue.
ACPE Universal Program Number:
207-000-09-003-H01-P
Release Date: March 1, 2009
Expiration Date: March 1, 2012
Statement
of Need
More
than 100 million Americans age 20 and older have high cholesterol. The
Third Report of the National Cholesterol Education Program (NCEP III)
Expert Panel established guidelines for identifying, diagnosing and
treating these patients. Patients are using alternative treatments for
dyslipidemia more than ever. Pharmacists armed with appropriate
knowledge on these natural products can educate patients to make
informed decisions about their care. Pharmacists should be familiar
with efficacy, safety, drug interactions, monitoring and dosing
strategies for commonly used complementary therapies.
Learning
Objectives
Upon
successful completion of this activity, the pharmacist should be able
to:
- Evaluate fasting lipid panels and establish goals for
therapy based on patient specific information.
- Identify natural products used for dyslipidemias.
- Outline role in therapy, adverse effects, and drug
interactions for each product.
- Select/recommend safe and effective natural products
for patients with dyslipidemias.
- Educate patients on appropriate use of natural
products for dyslipidemias.
Target
Audience
The
target audience for this activity is pharmacists.
Instructions
for Participation
To
receive a certificate of completion that indicates your eligibility for
continuing education credit, you must:
- Review the content of the activity.
- Successfully complete the post-test (70% or higher).
- You will have two (2) opportunities to successfully
complete the activity.
Your statement of credit will be issued immediately
upon successful completion of the post-test and submission of the
evaluation.
Fee
There
is no fee for this activity.
Accreditation
Pharmacists
NCPA is accredited by the Accreditation Council
for Pharmacy Education as a provider of continuing pharmacy education.
This program will provide 2.0 contact hours (.20 CEUs) of continuing
pharmacy education credit under the number 207-000-09-003-H01-P.
Faculty
Jennifer
M. Malinowski, PharmD,
is an assistant professor of pharmacy
practice at Wilkes University School of Pharmacy and a clinical
pharmacist
in Scranton, Pennsylvania.
Disclosure
Declaration
It
is
the policy of the National Community Pharmacists Association (NCPA) to
ensure independence, balance, objectivity, scientific rigor,
and integrity in all of their continuing education activities.
The author, sponsor, and publisher of
this continuing education activity have made all reasonable efforts
to ensure that information contained herein is accurate in accordance
with the latest available scientific knowledge at the time of
accreditation of this continuing education program. Information
regarding drugs (e.g., their administration, dosages,
contraindications,
adverse reactions, interactions, special warnings, precautions) and
drug delivery systems are subject to change, however, the reader is
advised to check the manufacturer's package insert for information
concerning recommended dosage and potential problems or cautions prior
to dispensing or administering the drug or using the drug delivery
systems.
Approval of credit for this continuing
education activity does not imply endorsement by NCPA of any product
or manufacturer identified.
Any medications or treatment methods suggested
in this CE activity should not be used by the practitioner
without evaluation of their patient's condition(s) and
possible contraindication(s) or danger(s) of use of any specific
medication.
Software
Requirements
PC
Internet Explorer 5.5 or greater
Firefox
Windows 2000 SE or greater
*Adobe Acrobat Reader |
MAC
Safari
Firefox
Internet Explorer is not supported on the Macintosh.
*Adobe Acrobat Reader
|
| *Required
to view Printable PDF Version |
Continue
|